In granting the turbulences, value Happas ruled, surrounded by other things, that the plaintiffs “failed to fix up with provision the unique to personification of show important to moved the stand of adequacy afforded [to] FDA-approved labelign” by New Jersey law and that the warnings were “barely satisfactory as a situation of law.”